{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 0,
        "end": 5
      }
    },
    {
      "id": "T3",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 10,
        "end": 14
      }
    },
    {
      "id": "T4",
      "obj": "Chemical",
      "span": {
        "begin": 125,
        "end": 128
      }
    },
    {
      "id": "T8",
      "obj": "Chemical",
      "span": {
        "begin": 191,
        "end": 208
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 125,
        "end": 144
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "18385200_4",
  "text": "C-MYC and DHFR protein levels at diagnosis were assessed by immunohistochemistry on series of patients treated with either a MTX -based protocol ( IOR/OS-1 ; 72 patients ) or with a standard four-drug regimen ( ISG/ SSG 1 ; 61 patients ) ."
}
